ProQR Therapeutics N.V. Ordinary Shares

PRQRNASDAQUSD
1.68 USD
0.10 (5.37%)🟢LIVE (AS OF 03:15 PM EDT)
🟢Market: OPEN

PRQR is currently priced at $1.68. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Jul 15, 2026.

Open?$1.77
High?$1.84
Low?$1.68
Prev. Close?$1.77
Volume?459.1K
Avg. Volume?N/A
VWAP?$1.69
Bid / Ask
Bid?$1.68 × 800
Ask?$1.69 × 800
Spread?$0.01
Midpoint?$1.69
Valuation & Ratios
Market Cap?249.8M
Shares Out?105.4M
Float?86.8M
Float %?82.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Employees
187
Market Cap
249.8M
Industry
N/A
Listed
2014-09-18
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.05Distress
Confidence?33%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.38%Low
Short Interest?1.2M
Days to Cover?1.0
Free Float86.8M
Avg Daily Volume2.0M
Settlement Date2026-06-30